Opaleye Management Inc., Ten Percent Owner at Harrow Health, holds 2.30M shares in Protara Therapeutics (Ticker: TARA), holds 3.81M shares in Harrow Health (Ticker: HROW), holds 0.00 shares in TRACON Pharmaceuticals (Ticker: TCON). Most recently, Opaleye Management Inc. Sold ― shares of Protara Therapeutics on Jun 28, 2024 for an estimated value of 142.04K.